Table 2.
Substance | Concentration 1 | Concentration 2 |
---|---|---|
Analgesics | ||
Fentanyl a | 500–1040 ng/mL c | 250–500 ng/mL c |
Metamizole b | 50 μg/mL | 10 μg/mL |
Paracetamol b | 10 μg/mL | 2 μg/mL |
Piritramide a | 5.5 μg/mL | 1.1 μg/mL |
Remifentanil a | 60 ng/mL | 30 ng/mL |
Sufentanil a | 440–640 ng/mL c | 220–320 ng/mL c |
Tramadol a | 100 mg/mL | 20 mg/mL |
Antibiotics | ||
Ampicillin b | 10 mg/mL | 2 mg/mL |
Cefazolin b | 2.5 mg/mL | 0.5 mg/mL |
Cefuroxime b | 2.5 mg/mL | 0.5 mg/mL |
Ciprofloxacin b | 100 μg/mL | 20 μg/mL |
Clindamycin a | 220 μg/mL | 110 μg/mL |
PPL b | 50 μg/mL | 10 μg/mL |
MDM b | 1 mg/mL | 0.2 mg/mL |
Local anesthetics | ||
Bupivacaine b | 400 μg/mL | 80 μg/mL |
Lidocaine b | 250 μg/mL | 50 μg/mL |
Mepivacaine b | 400 μg/mL | 80 μg/mL |
Ropivacaine a | 800 μg/mL | 400 μg/mL |
Narcotics | ||
Etomidate a | 2.94 μg/mL | 1.47 μg/mL |
Midazolam a | 11 ng/mL | 5.5 ng/mL |
Propofol b | 1 mg/mL | 0.2 mg/mL |
Pyridostigmine a | 22 μg/mL | 11 μg/mL |
Thiopental a | 0.38–0.44 mg/mL c | 0.19–0.22 mg/mL c |
NMBA | ||
Atracurium b | 5 μg/mL | 1 μg/mL |
Cisatracurium b | 400 μg/mL | 80 μg/mL |
Mivacurium b | 1 mg/mL | 0.2 mg/mL |
Neuromuscular blocking mix b | 4.3 mg/mL | 0.86 mg/mL |
Pancuronium b | 1 mg/mL | 0.2 mg/mL |
Rocuronium b | 1 mg/mL | 0.2 mg/mL |
Suxamethonium b | 10 mg/mL | 2 mg/mL |
Vecuronium b | 250 μg/mL | 50 μg/mL |
Others | ||
Dexamethasone a | 5.86 μg/mL | 2.93 μg/mL |
Hydroxyethyl starch a | 60 μg/mL | 12 μg/mL |
Patent blue V b | 250 μg/mL | 50 μg/mL |
Suprarenin a | 0.146 μg/mL | 0.073 μg/mL |
Commercially available medication.
Purchased from BÜHLMANN Laboratories AG, Schönenbuch, Switzerland.
Concentration depending on body weight of the patient.